FMACX
Price
$44.01
Change
-$0.95 (-2.11%)
Updated
Feb 21 closing price
Net Assets
89.95B
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

FMACX vs GFACX

Header iconFMACX vs GFACX Comparison
Open Charts FMACX vs GFACXBanner chart's image
American Funds AMCAP F3
Price$44.01
Change-$0.95 (-2.11%)
VolumeN/A
Net Assets89.95B
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
FMACX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FMACX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMACX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. FMACX (90B). FMACX pays higher dividends than GFACX: FMACX (0.99) vs GFACX (0.00). FMACX was incepted earlier than GFACX: FMACX (8 years) vs GFACX (24 years). FMACX (31.00) and GFACX (31.00) have comparable annual turnover. GFACX has a lower initial minimum investment than FMACX: GFACX (250) vs FMACX (1000000). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. FMACX (7.27). GFACX return over 5 years is better than : 32.83 vs. FMACX (28.77).
FMACXGFACXFMACX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD2.1352.98072%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets90B304B30%
Annual Yield % from dividends0.990.00-
Returns for 1 year7.2710.1572%
Returns for 3 years15.5917.6988%
Returns for 5 years28.7732.8388%
Returns for 10 yearsN/A55.63-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding